Controversy: the essence of medical debate.
Donnan
Geoffrey A
GA
National Stroke Research Institute, Austin and Repatriation Medical Center and the University of Melbourne, Victoria , Australia. gdonnan@unimelb.edu.au
Davis
Stephen M
SM
D000925:Anticoagulants / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000592:standards; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D008279:Magnetic Resonance Imaging; D018579:Patient Selection; D012107:Research Design; D018570:Risk Assessment; D020521:Stroke / Q000175:diagnosis / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000009:adverse effects; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator